DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer-Reference-Cited by-同舟云学术

DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer

Published:2021-03 Issue: Volume:501 Page:224-233
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Moskovich Dotan,Alfandari Adi,Finkelshtein Yael,Weisz Avivit,Katzav Aviva,Kidron Debora,Edelstein Evgeny,Veroslavski Daniel,Perets Ruth,Arbib Nissim,Kadan Yfat,Fishman Ami^ORCID,Lerer Bernard^ORCID,Ellis Martin,Ashur-Fabian Osnat^ORCID

Funder

Faculty of Medicine

Tel Aviv University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Ovarian cancer;Jayson;Lancet,2014

2. High grade serous ovarian carcinomas originate in the fallopian tube;Labidi-Galy;Nat. Commun.,2017

3. It's totally tubular riding the new wave of ovarian cancer research;Perets;Canc. Res.,2016

4. Understanding the Warburg effect: the metabolic requirements of cell proliferation;Vander Heiden;Science,2009

5. Role of thyroid hormones in the neoplastic process: an overview;Goemann;Endocr. Relat. Canc.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer;Molecular Oncology;2024-03

2. Corrigendum to “DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer” [Canc. Lett. 501 224–233];Cancer Letters;2023-06

3. Molecular mechanisms and prognostic value of the selenoprotein gene family in lung adenocarcinoma and lung squamous cell carcinoma;2023-05-11

4. Deiodinases in thyroid tumorigenesis;Endocrine-Related Cancer;2023-03-02

5. Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase;Pharmacological Research;2023-03